4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine

C29H31N5O2 — CID 144996948

IUPAC4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine
SMILESCN1CCCCC1.COc1cc(-c2ccc(C#N)cc2)c(-c2cnc3c(c2)CCCO3)n2cncc12
InChIInChI=1S/C23H18N4O2.C6H13N/c1-28-21-10-19(16-6-4-15(11-24)5-7-16)22(27-14-25-13-20(21)27)18-9-17-3-2-8-29-23(17)26-12-18;1-7-5-3-2-4-6-7/h4-7,9-10,12-14H,2-3,8H2,1H3;2-6H2,1H3
InChIKeyALGXPKJWXHOBKN-UHFFFAOYSA-N
MW481.60 g/mol
LogP5.37
Rot. Bonds3

About 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine

4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine (PubChem CID 144996948) has the molecular formula C29H31N5O2 and a molecular weight of 481.60 g/mol. Its IUPAC name is 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine.

Molecular Properties

Compound Name4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine
PubChem CID144996948
Molecular FormulaC29H31N5O2
Molecular Weight481.60 g/mol
Exact Mass481.25
IUPAC Name4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine
SMILESCN1CCCCC1.COc1cc(-c2ccc(C#N)cc2)c(-c2cnc3c(c2)CCCO3)n2cncc12
InChIInChI=1S/C23H18N4O2.C6H13N/c1-28-21-10-19(16-6-4-15(11-24)5-7-16)22(27-14-25-13-20(21)27)18-9-17-3-2-8-29-23(17)26-12-18;1-7-5-3-2-4-6-7/h4-7,9-10,12-14H,2-3,8H2,1H3;2-6H2,1H3
InChIKeyALGXPKJWXHOBKN-UHFFFAOYSA-N
XLogP5.37
TPSA75.68 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500481.60
LogP ≤ 55.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine?
The IUPAC name of 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine (CID 144996948) is 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine.
What is the SMILES notation for 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine?
The canonical SMILES for 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine is CN1CCCCC1.COc1cc(-c2ccc(C#N)cc2)c(-c2cnc3c(c2)CCCO3)n2cncc12.
What is the InChIKey of 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine?
The InChIKey is ALGXPKJWXHOBKN-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H18N4O2.C6H13N/c1-28-21-10-19(16-6-4-15(11-24)5-7-16)22(27-14-25-13-20(21)27)18-9-17-3-2-8-29-23(17)26-12-18;1-7-5-3-2-4-6-7/h4-7,9-10,12-14H,2-3,8H2,1H3;2-6H2,1H3.
What are the key properties of 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine?
4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine has a molecular weight of 481.60 g/mol, XLogP of 5.37, 3 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(3,4-dihydro-2H-pyrano[2,3-b]pyridin-6-yl)-8-methoxyimidazo[1,5-a]pyridin-6-yl]benzonitrile;1-methylpiperidine is sourced from PubChem (CID 144996948), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).